← Leaderboards
Mayte Coiras
Utah State Higher Education System--University Of Utah
$1,144,469
Attributed
$2,288,937
Total exposure
1
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $509.2K · FY2019–23$1M$750K$500K$250K$0
'19
'20
'21
'22
'23
Funding mix
By agency
NIH$2,288,937 · 1
By mechanism
R01$2,288,937 · 1
Top collaborators
- Vicente Planelles5 shared
Most similar at Utah State Higher Education System--University Of Utah
Same institution · by research overlap
- Vicente Planelles$15,017,567
- Anna E Beaudin$5,420,737
- Mingnan Chen$4,920,350
Others in their field
Other Emerging Leaders on “Abl1 Gene”
- Pora Kim · University Of Texas Hlth Sci Ctr Houston$1,710,690
- Shahana Sultana Mahajan · Hunter College$1,560,000
- Mehdi Mollapour · Syracuse Va Medical Center$995,550
- Christina U Lorentz · Aronora, Inc.$835,601
- Zhaohui Gu · St. Jude Children'S Research Hospital$517,090
- Anna Marie Eiring · Texas Tech University Health Scis Center$510,980
Research focus
Abl1 GeneFrontierAffectAntiviral ResponseAntiretroviral TherapyBiologicalCd3 AntigensCd4 Positive T LymphocytesCd8-Positive T-LymphocytesCellsCell TypeAwarenessChronic Myeloid LeukemiaClinical ApplicationClinical TrialsCytokineCytomegalovirusCytotoxicDasatinibFcgr3b GeneFda ApprovedFightingFrequenciesFuture
Grant awards (5)
Tyrosine Kinase inhibition: The New Front in HIV Cure Efforts$442,650
R01 · FY2023 · AI
Tyrosine Kinase inhibition: The New Front in HIV Cure Efforts$410,850
R01 · FY2022 · AI
Tyrosine Kinase inhibition: The New Front in HIV Cure Efforts$454,331
R01 · FY2021 · AI
Tyrosine Kinase inhibition: The New Front in HIV Cure Efforts$471,902
R01 · FY2020 · AI
Tyrosine Kinase inhibition: The New Front in HIV Cure Efforts$509,204
R01 · FY2019 · AI